144 related articles for article (PubMed ID: 22570180)
1. MET expression in melanoma correlates with a lymphangiogenic phenotype.
Swoboda A; Schanab O; Tauber S; Bilban M; Berger W; Petzelbauer P; Mikula M
Hum Mol Genet; 2012 Aug; 21(15):3387-96. PubMed ID: 22570180
[TBL] [Abstract][Full Text] [Related]
2. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.
Dadras SS; Lange-Asschenfeldt B; Velasco P; Nguyen L; Vora A; Muzikansky A; Jahnke K; Hauschild A; Hirakawa S; Mihm MC; Detmar M
Mod Pathol; 2005 Sep; 18(9):1232-42. PubMed ID: 15803182
[TBL] [Abstract][Full Text] [Related]
3. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
[TBL] [Abstract][Full Text] [Related]
4. Wnt1 is anti-lymphangiogenic in a melanoma mouse model.
Niederleithner H; Heinz M; Tauber S; Bilban M; Pehamberger H; Sonderegger S; Knöfler M; Bracher A; Berger W; Loewe R; Petzelbauer P
J Invest Dermatol; 2012 Sep; 132(9):2235-44. PubMed ID: 22572818
[TBL] [Abstract][Full Text] [Related]
5. Tumor lymphangiogenesis and melanoma metastasis.
Rinderknecht M; Detmar M
J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.
Bracher A; Cardona AS; Tauber S; Fink AM; Steiner A; Pehamberger H; Niederleithner H; Petzelbauer P; Gröger M; Loewe R
J Invest Dermatol; 2013 Jan; 133(1):230-8. PubMed ID: 22951723
[TBL] [Abstract][Full Text] [Related]
7. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
8. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
9. Activin A is anti-lymphangiogenic in a melanoma mouse model.
Heinz M; Niederleithner HL; Puujalka E; Soler-Cardona A; Grusch M; Pehamberger H; Loewe R; Petzelbauer P
J Invest Dermatol; 2015 Jan; 135(1):212-221. PubMed ID: 25084052
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker.
Zhao D; Wang SH; Feng Y; Hua CG; Zhao J; Tang XF
Hum Pathol; 2011 Oct; 42(10):1514-23. PubMed ID: 21531000
[TBL] [Abstract][Full Text] [Related]
11. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
12. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
13. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
Massi D; Puig S; Franchi A; Malvehy J; Vidal-Sicart S; González-Cao M; Baroni G; Ketabchi S; Palou J; Santucci M
J Clin Pathol; 2006 Feb; 59(2):166-73. PubMed ID: 16443733
[TBL] [Abstract][Full Text] [Related]
14. Lymphangiogenesis and Anti-lymphangiogenesis in Cutaneous Melanoma.
Raica M; Jitariu AA; Cimpean AM
Anticancer Res; 2016 Sep; 36(9):4427-35. PubMed ID: 27630278
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
16. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
17. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma.
Pastushenko I; Vermeulen PB; Vicente-Arregui S; Van den Eynden GG; Alvarez-Alegret R; Querol I; Rutten A; Carapeto FJ; Dirix LY; Van Laere S
J Cutan Pathol; 2015 Oct; 42(10):699-711. PubMed ID: 26264662
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.
Buzrla P; Dvorackova J; Motyka O
Biomed Res Int; 2014; 2014():372979. PubMed ID: 25089267
[TBL] [Abstract][Full Text] [Related]
19. Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
Gallego E; Vicioso L; Alvarez M; Hierro I; Pérez-Villa L; Blanes A; Matilla A
Virchows Arch; 2011 May; 458(5):621-30. PubMed ID: 21279519
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma.
Monteiro AC; Muenzner JK; Andrade F; Rius FE; Ostalecki C; Geppert CI; Agaimy A; Hartmann A; Fujita A; Schneider-Stock R; Jasiulionis MG
Mol Oncol; 2019 Jun; 13(6):1433-1449. PubMed ID: 31069961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
